tirzepatide and mash fda Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH Let's talk about Tirzepatide and

Tirzepatide targets key hormones in your body that regulate appetite and insulin sensitivity

It belongs to a novel class of agents known as triple hormone receptor agonists, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

Orforglipron is a once-daily, orally administered, non-peptide GLP-1 receptor agonist that operates in a slightly different manner from natural GLP-1

Cardiovascular benefits: May reduce the risk of major adverse cardiovascular events (MACE)

Whether you need help developing clinical workflows, nutrition frameworks, staff training, patient education, or ongoing quality improvement, I can partner with you to create a program that meets the needs